CIK 0001178670 · Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770602661
- Phone
- (617) 551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$543,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | PYOTT DAVID E I Director | Option exercise | +3,780 | $71.99 | $272K | 5,362 |
| 2026-11-10 | PYOTT DAVID E I Director | Option exercise · Stock Option (Right to Buy) | −3,780 | 0 | ||
| 2026-11-10 | Sigal Charles Elliott Director | Purchase | +1,600 | $152.25 | $244K | 3,600 |
| 2026-11-09 | SCHULMAN AMY W Director | Purchase | +1,910 | $156.82 | $300K | 25,959 |
Page 1 of 1 · 4 trades